small molecule

PANTOPRAZOLE SODIUM

PANTOPRAZOLE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand namePANTOPRAZOLE SODIUM
Active ingredientPANTOPRAZOLE SODIUM
StrengthEQ 20MG BASE
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.